Latozinemab (AL001) is a potent and selective recombinant humanized monoclonal antibody against Sortilin.Latozinemab has a high affinity for Sortilin and interrupts the interaction between the granule protein precursor (PGRN) and the Sortilin receptor.Latozinemab can be used to study of dementia and Alzheimers disease.
Purity:
>95%
Target:
Neurotensin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted